Dr. Andres Soriano, M.D.
What this data tells you about Dr. Soriano
Dr. Andres Soriano is a hematology in North Venice, FL, with 18 years in practice. Based on federal Medicare data, Dr. Soriano performed 266,807 Medicare services across 6,094 unique beneficiaries.
Between the years covered by Open Payments, Dr. Soriano received a total of $12,164 from 75 pharmaceutical and/or device companies across 616 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Soriano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 87,210 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 22,800 | $43 | $137 |
| Azacitidine chemotherapy injection | 22,200 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 21,671 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 18,330 | $1 | $5 |
| Iron infusion (Injectafer) | 17,250 | $1 | $3 |
| Oxaliplatin chemotherapy injection | 11,600 | $0 | $12 |
| Denosumab injection (Prolia/Xgeva) | 10,920 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 9,252 | $36 | $108 |
| Iron sucrose injection (Venofer) | 7,984 | $0 | $5 |
| Iron infusion (Monoferric) | 7,300 | $16 | $57 |
| Dexamethasone injection (steroid) | 3,947 | $0 | $3 |
| Complete blood count (CBC) with differential | 3,549 | $8 | $29 |
| Blood draw (venipuncture) | 3,423 | $8 | $9 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,460 | $24 | $185 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,900 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,896 | $97 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 1,324 | $0 | $9 |
| Contrast dye for imaging (iodine-based) | 1,161 | $0 | $1 |
| Injection of additional new drug or substance into vein | 1,117 | $12 | $61 |
| Drug injection, under skin or into muscle | 1,048 | $10 | $69 |
| Injection, leucovorin calcium, per 50 mg | 1,034 | $3 | $12 |
| Administration of chemotherapy into vein, 1 hour or less | 706 | $97 | $378 |
| Injection, fluorouracil, 500 mg | 674 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 536 | $47 | $189 |
| Injection, zoledronic acid, 1 mg | 429 | $6 | $69 |
| Injection, carboplatin, 50 mg | 348 | $2 | $41 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 280 | $3 | $205 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 278 | $16 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 274 | $15 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 266 | $1 | $3 |
| Office visit, established patient (20-29 min) | 249 | $64 | $239 |
| Injection, cisplatin, powder or solution, 10 mg | 249 | $2 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 241 | $22 | $84 |
| Infusion into a vein for hydration, each additional hour | 208 | $10 | $42 |
| Office visit, established patient, complex (40-54 min) | 192 | $138 | $474 |
| Administration of additional new drug or substance into vein, 1 hour or less | 186 | $48 | $178 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 185 | $54 | $206 |
| Injection of drug or substance into vein | 182 | $28 | $156 |
| Administration of chemotherapy into vein, each additional hour | 179 | $21 | $79 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 177 | $1 | $6 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 171 | $3 | $11 |
| Infusion, normal saline solution , 1000 cc | 128 | $2 | $7 |
| New patient office visit (45-59 min) | 121 | $126 | $453 |
| Injection, magnesium sulfate, per 500 mg | 114 | $1 | $2 |
| Prothrombin time test (blood clotting) | 104 | $4 | $15 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 101 | $24 | $89 |
| Red blood count automated, with additional calculations | 96 | $5 | $20 |
| New patient office visit, complex (60-74 min) | 87 | $162 | $585 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $135 | $562 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 81 | $129 | $637 |
| Administration of additional new drug or substance into vein using push technique | 70 | $42 | $170 |
| Automated urinalysis | 63 | $2 | $8 |
| Initial hospital admission, high complexity | 62 | $136 | $556 |
| Infusion into a vein for hydration, 31-60 minutes | 58 | $24 | $156 |
| Hospital follow-up visit, moderate complexity | 57 | $63 | $197 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 51 | $15 | $56 |
| Drawing of blood for a medical problem | 35 | $72 | $277 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 35 | $1 | $7 |
| Injection, alteplase recombinant, 1 mg | 26 | $69 | $218 |
| Hospital follow-up visit, high complexity | 22 | $94 | $285 |
| Ct scan of chest with contrast | 14 | $54 | $359 |
| CT scan of abdomen and pelvis with contrast | 12 | $174 | $550 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Soriano is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Soriano experienced with iron infusion (feraheme)?
Does Dr. Soriano receive payments from pharmaceutical companies?
How do Dr. Soriano's costs compare to other hematologys in North Venice?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology